Post-approval studies (Phase 4)Study completedNCT05824767
What this trial is testing
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
Who this might be right for
Septic ShockVasodilatory Shock
University of New Mexico 40
Showing 3 of 3 results